939 related articles for article (PubMed ID: 25770317)
1. Eicosapentaenoic acid in cancer improves body composition and modulates metabolism.
Pappalardo G; Almeida A; Ravasco P
Nutrition; 2015 Apr; 31(4):549-55. PubMed ID: 25770317
[TBL] [Abstract][Full Text] [Related]
2. Effects of an oral nutritional supplement containing eicosapentaenoic acid on nutritional and clinical outcomes in patients with advanced non-small cell lung cancer: randomised trial.
Sánchez-Lara K; Turcott JG; Juárez-Hernández E; Nuñez-Valencia C; Villanueva G; Guevara P; De la Torre-Vallejo M; Mohar A; Arrieta O
Clin Nutr; 2014 Dec; 33(6):1017-23. PubMed ID: 24746976
[TBL] [Abstract][Full Text] [Related]
3. Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial.
Read JA; Beale PJ; Volker DH; Smith N; Childs A; Clarke SJ
Support Care Cancer; 2007 Mar; 15(3):301-7. PubMed ID: 17021855
[TBL] [Abstract][Full Text] [Related]
4. Polyunsaturated fatty acids in cancer and their influence on biochemical and metabolic events and body composition.
Das UN
Nutrition; 2015 Apr; 31(4):582-4. PubMed ID: 25770320
[No Abstract] [Full Text] [Related]
5. Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia.
Biolo G; Cederholm T; Muscaritoli M
Clin Nutr; 2014 Oct; 33(5):737-48. PubMed ID: 24785098
[TBL] [Abstract][Full Text] [Related]
6. Sarcopenia and cachexia in the era of obesity: clinical and nutritional impact.
Prado CM; Cushen SJ; Orsso CE; Ryan AM
Proc Nutr Soc; 2016 May; 75(2):188-98. PubMed ID: 26743210
[TBL] [Abstract][Full Text] [Related]
7. Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia.
Fearon KC; Barber MD; Moses AG; Ahmedzai SH; Taylor GS; Tisdale MJ; Murray GD
J Clin Oncol; 2006 Jul; 24(21):3401-7. PubMed ID: 16849754
[TBL] [Abstract][Full Text] [Related]
8. Enteral nutrition enriched with eicosapentaenoic acid (EPA) preserves lean body mass following esophageal cancer surgery: results of a double-blinded randomized controlled trial.
Ryan AM; Reynolds JV; Healy L; Byrne M; Moore J; Brannelly N; McHugh A; McCormack D; Flood P
Ann Surg; 2009 Mar; 249(3):355-63. PubMed ID: 19247018
[TBL] [Abstract][Full Text] [Related]
9. Effects of eicosapentaenoic acid (EPA) treatment on insulin sensitivity in an animal model of diabetes: improvement of the inflammatory status.
Figueras M; Olivan M; Busquets S; López-Soriano FJ; Argilés JM
Obesity (Silver Spring); 2011 Feb; 19(2):362-9. PubMed ID: 20885391
[TBL] [Abstract][Full Text] [Related]
10. Cancer-associated malnutrition, cachexia and sarcopenia: the skeleton in the hospital closet 40 years later.
Ryan AM; Power DG; Daly L; Cushen SJ; Ní Bhuachalla Ē; Prado CM
Proc Nutr Soc; 2016 May; 75(2):199-211. PubMed ID: 26786393
[TBL] [Abstract][Full Text] [Related]
11. Cancer-associated malnutrition.
Argilés JM
Eur J Oncol Nurs; 2005; 9 Suppl 2():S39-50. PubMed ID: 16437757
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of lipid mobilization associated with cancer cachexia: interaction between the polyunsaturated fatty acid, eicosapentaenoic acid, and inhibitory guanine nucleotide-regulatory protein.
Tisdale MJ
Prostaglandins Leukot Essent Fatty Acids; 1993 Jan; 48(1):105-9. PubMed ID: 8380931
[TBL] [Abstract][Full Text] [Related]
13. [The relevance of body composition in cancer patients: what is the evidence?].
Coronha AL; Camilo ME; Ravasco P
Acta Med Port; 2011 Dec; 24 Suppl 4():769-78. PubMed ID: 22863483
[TBL] [Abstract][Full Text] [Related]
14. EPA-enriched phospholipids ameliorate cancer-associated cachexia mainly via inhibiting lipolysis.
Du L; Yang YH; Wang YM; Xue CH; Kurihara H; Takahashi K
Food Funct; 2015 Dec; 6(12):3652-62. PubMed ID: 26373883
[TBL] [Abstract][Full Text] [Related]
15. Effect of Eicosapentaenoic Acid on Body Composition and Inflammation Markers in Patients with Head and Neck Squamous Cell Cancer from a Public Hospital in Mexico.
Solís-Martínez O; Plasa-Carvalho V; Phillips-Sixtos G; Trujillo-Cabrera Y; Hernández-Cuellar A; Queipo-García GE; Meaney-Mendiolea E; Ceballos-Reyes GM; Fuchs-Tarlovsky V
Nutr Cancer; 2018; 70(4):663-670. PubMed ID: 29697274
[TBL] [Abstract][Full Text] [Related]
16. Anorexia-cachexia syndrome: a systematic review of the role of dietary polyunsaturated Fatty acids in the management of symptoms, survival, and quality of life.
Mazzotta P; Jeney CM
J Pain Symptom Manage; 2009 Jun; 37(6):1069-77. PubMed ID: 19054647
[TBL] [Abstract][Full Text] [Related]
17. Role of n-3 fatty acids in muscle loss and myosteatosis.
Ewaschuk JB; Almasud A; Mazurak VC
Appl Physiol Nutr Metab; 2014 Jun; 39(6):654-62. PubMed ID: 24869970
[TBL] [Abstract][Full Text] [Related]
18. New strategies to overcome cancer cachexia: from molecular mechanisms to the 'Parallel Pathway'.
Muscaritoli M; Costelli P; Aversa Z; Bonetto A; Baccino FM; Rossi Fanelli F
Asia Pac J Clin Nutr; 2008; 17 Suppl 1():387-90. PubMed ID: 18296386
[TBL] [Abstract][Full Text] [Related]
19. [Recent development in research and management of cancer anorexia-cachexia syndrome].
Inui A
Gan To Kagaku Ryoho; 2005 Jun; 32(6):743-9. PubMed ID: 15984510
[TBL] [Abstract][Full Text] [Related]
20. A disease-specific enteral nutrition formula improves nutritional status and functional performance in patients with head and neck and esophageal cancer undergoing chemoradiotherapy: results of a randomized, controlled, multicenter trial.
Fietkau R; Lewitzki V; Kuhnt T; Hölscher T; Hess CF; Berger B; Wiegel T; Rödel C; Niewald M; Hermann RM; Lubgan D
Cancer; 2013 Sep; 119(18):3343-53. PubMed ID: 23765693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
